Analysis of ▫ 36A, anintegrated HBV DNA and its cellular flanking sequences clonod from a human hepatocellular carcinoma cell line HCC36, and construction of a cDNA library from HCC 36

Analysis of ▫ 36A, anintegrated HBV DNA and its cellular flanking sequences clonod from a human hepatocellular carcinoma cell line HCC36, and construction of a cDNA library from HCC 36

碩士 === 國立臺灣大學 === 微生物研究所 === 75 ===

Bibliographic Details
Main Authors:	LIN, YI-LING, 林宜玲
Other Authors:	CHEN, ZHEN-YANG
Format:	Others
Language:	zh-TW
Published:	1987
Online Access:	http://ndltd.ncl.edu.tw/handle/34740816730930970350

Similar Items

Analysis of an integrated HBV DNA and its cellular flanking sequence,(29436B, derived from a human hepatocellular carcinoma cell line HCC36 and construction of a genomic library from HCC36
by: CHEN, MEI-LING, et al.
Published: (1987)

由人類肝癌細胞株HCC36中選殖的λ36CDNA的分析
by: CUI, DAO-ZHEN, et al.

Occult HBV infection and HCC
by: Isabelle Chemin
Published: (2007-02-01)

HBV-Induced Immune Imbalance in the Development of HCC
by: Yongyan Chen, et al.
Published: (2019-08-01)

Human Hepatocellular Carcinoma (HCC)
by: Luigi Buonaguro
Published: (2020-12-01)

Foamy Histiocyte-Like Hepatocellular Carcinoma (HCC): A New Variant of HCC?
by: Richard Dunn, et al.
Published: (2017-03-01)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Chen, L., et al.
Published: (2022)

The Assessment of Using Plasma HBV DNA level as A Prognostic Marker on HCC Patients After Resection
by: 鄭光洪
Published: (2010)

An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm
by: Kelly W Burak, et al.
Published: (2010-01-01)

Hepatocellular carcinoma (HCC) biomarkers in Colombia
by: María Cristina Navas
Published: (2007-02-01)

Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCC
by: Charing Ching-Ning Chong, et al.
Published: (2016-03-01)

Inverse polymerase Chian reaction (IPCR) to clone cellular sequences adjacent to integrated hepatitis B virus (HBV) DNA in hepatocellular carcinomas (HCC)
by: Yin, Zhi Xiong, et al.
Published: (1995)

HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level
by: Ambreen Ayub, et al.
Published: (2013-01-01)

Study Alcohol Metabolism genes in hepatocellular carcinoma (HCC) and its association with prognosis of HCC patients
by: Hsiang Yao Wu, et al.
Published: (2009)

Apostillas dermatológicas 36 Dermatologic notes 36
by: N E Driban, et al.
Published: (2007-12-01)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
by: Yanyan Wei, et al.
Published: (2018-02-01)

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
by: Xiaoqing Luo, et al.
Published: (2021-03-01)

Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC)
by: Masanori Oshi, et al.
Published: (2021-01-01)

Catulus’ Speech in Cassius Dio 36.31–36
by: Barbara Saylor Rodgers
Published: (2010-11-01)

Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36[S]
by: Latisha Love-Gregory, et al.
Published: (2016-12-01)

Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-06-01)

TLR3 Plays Significant Roles against HBV-Associated HCC
by: Xiao-lan Chen, et al.
Published: (2015-01-01)

A36
by: E. Voropaeva, et al.
Published: (2015-11-01)

Volume 36
by: Revista Alfa
Published: (2001-02-01)

Analysis of integrated HBV DNA and flanking cellular sequences in HBV-related hepatocellular carcinoma and adjacent liver tissue by IPCR
by: Wu, Fang Zi, et al.
Published: (1996)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
by: Eugenia Bezzecchi, et al.
Published: (2020-12-01)

Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
by: Wafaa M. Rashed, et al.
Published: (2020-01-01)

Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
by: Monika Pazgan-Simon, et al.
Published: (2020-01-01)

Recent perspectives in hepatocellular carcinoma (HCC) diagnosis and treatment
by: WANG Aiping
Published: (2013-01-01)

Adenovirus 36 DNA in Adipose Tissue of Patient with Unusual Visceral Obesity
by: Behrouz Salehian, et al.
Published: (2010-05-01)

The Evaluation of Pharmacodynamics and Pharmacokinetics of Anti-thrombin DNA Aptamer RA-36
by: Elena Zavyalova, et al.
Published: (2017-12-01)

Spinocerebellar ataxia 36 (SCA36): “Costa da Morte ataxia”
by: M. Arias, et al.
Published: (2017-07-01)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
by: Stefania Madonna, et al.
Published: (2019-07-01)

Structural and functional consequences of Connexin 36 (Cx36) interaction with Calmodulin
by: Ryan CF Siu, et al.
Published: (2016-11-01)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
by: Vicki Wing-Ki Hui, et al.
Published: (2020-12-01)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-12-01)

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
by: Zhifeng Zhao, et al.
Published: (2021-09-01)

Using cell-free DNA for HCC surveillance and prognosisKey points
by: Nguyen H. Tran, et al.
Published: (2021-08-01)

H3K36me3, message from chromatin to DNA damage repair
by: Zhongxing Sun, et al.
Published: (2020-01-01)